東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Fatty liver." ]

切換: 標籤 | MARC模式 | ISBD

Alcoholic and non-alcoholic fatty li...

Chalasani, Naga.

FindBook

Google Book

Amazon

博客來

Alcoholic and non-alcoholic fatty liver disease = bench to bedside /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Alcoholic and non-alcoholic fatty liver disease/ edited by Naga Chalasani, Gyongyi Szabo.
其他題名:	bench to bedside /
其他作者:	Chalasani, Naga.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xvi, 372 p. :ill. (some col.), digital ;24 cm.
內容註:	Epidemiology and Risk Factors for Alcoholic Liver Disease -- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease -- Pathogenesis of Alcoholic Liver Disease -- Pathogenesis of NAFLD and NASH -- Animal Models of Alcoholic Liver Disease -- Animal Models of Nonalcoholic Fatty Liver Disease -- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease -- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease -- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History -- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease -- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis -- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease -- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease -- Hepatic and Extra-Hepatic Malignancies in NAFLD -- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation -- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease -- Nonalcoholic Fatty Liver Disease in Children.
Contained By:	Springer eBooks
標題:	Fatty liver. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-20538-0
ISBN:	9783319205380$q(electronic bk.)

Alcoholic and non-alcoholic fatty liver disease = bench to bedside /
Alcoholic and non-alcoholic fatty liver diseasebench to bedside /[electronic resource] :edited by Naga Chalasani, Gyongyi Szabo. - Cham :Springer International Publishing :2016. - xvi, 372 p. :ill. (some col.), digital ;24 cm.

Epidemiology and Risk Factors for Alcoholic Liver Disease -- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease -- Pathogenesis of Alcoholic Liver Disease -- Pathogenesis of NAFLD and NASH -- Animal Models of Alcoholic Liver Disease -- Animal Models of Nonalcoholic Fatty Liver Disease -- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease -- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease -- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History -- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease -- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis -- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease -- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease -- Hepatic and Extra-Hepatic Malignancies in NAFLD -- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation -- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease -- Nonalcoholic Fatty Liver Disease in Children.

This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies. Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.

ISBN: 9783319205380$q(electronic bk.)

Standard No.: 10.1007/978-3-319-20538-0doiSubjects--Topical Terms:

2181360
Fatty liver.

LC Class. No.: RC848.F3

Dewey Class. No.: 616.362

Alcoholic and non-alcoholic fatty liver disease = bench to bedside /
LDR:02753nmm a2200313 a 4500 001 2030009
003 DE-He213
005 20160809161815.0
006 m d
007 cr nn 008maaau
008 160908s2016 gw s 0 eng d
020 $a 9783319205380$q(electronic bk.)
020 $a 9783319205373$q(paper)
024 7 $a 10.1007/978-3-319-20538-0 $2 doi
035 $a 978-3-319-20538-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b A354 2016
245 0 0 $a Alcoholic and non-alcoholic fatty liver disease $h [electronic resource] : $b bench to bedside / $c edited by Naga Chalasani, Gyongyi Szabo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 372 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Epidemiology and Risk Factors for Alcoholic Liver Disease -- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease -- Pathogenesis of Alcoholic Liver Disease -- Pathogenesis of NAFLD and NASH -- Animal Models of Alcoholic Liver Disease -- Animal Models of Nonalcoholic Fatty Liver Disease -- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease -- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease -- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History -- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease -- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis -- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease -- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease -- Hepatic and Extra-Hepatic Malignancies in NAFLD -- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation -- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease -- Nonalcoholic Fatty Liver Disease in Children.
520 $a This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies. Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.
650 0 $a Fatty liver. $3 2181360
650 0 $a Liver $x Diseases. $3 805374
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Pathology. $3 643180
650 2 4 $a Hepatology. $3 894467
700 1 $a Chalasani, Naga. $3 2181358
700 1 $a Szabo, Gyongyi. $3 2181359
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-20538-0
950 $a Medicine (Springer-11650)